Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute of Mental Health (NIMH) |
---|---|
Information provided by: | National Institutes of Health Clinical Center (CC) |
ClinicalTrials.gov Identifier: | NCT00298246 |
The purpose of this study is to learn more about autism and its subtypes. Autism is a developmental disorder in which children have problems with communication and social skills and display restricted interests and repetitive behaviors.
This study has several goals. One aim is to look at types of autism that are known, such as the regressive subtype, (where skills are lost). We will explore whether there is a unique change in immune functioning related to this subtype. Another aim is to serve as one of the sites that will pilot a larger natural history study, entitled Autism Phenome Project. The goal is to further understand autism by identifying other subtypes.
We will look at several types of medical issues that may be related to autism, including immunologic problems. Children will be followed over the course of several years. We aim to capture medical problems that may be related to autism as they develop, and study outcomes in areas such as behavior and language, in order to explore known and new subtypes of autism.
Normally developing children (aged 1-6) and children with autism (age 1-6), developmental delays other than autism (age 2-6), or Rett's disorder (age 1-4) may be eligible for this study.
Depending on each child's study group and age, participants may undergo the following tests and procedures:
Baseline Visit
Follow-Up Visits
Follow-up visits are scheduled at different intervals, depending on study group, age and aspect of the study the child is enrolled in. The visits include a short interview session with the child's caregiver and assessment of the child's development and behavior. Some of the assessment measures used during the baseline examination are repeated, including symptoms ratings, behavioral tests and a blood test. For some children, the final visit will include repeats of the medical procedures.
Condition |
---|
Autism |
Study Type: | Observational |
Official Title: | Clinical and Immunological Investigations of Subtypes of Autism |
Ages Eligible for Study: | 1 Year to 6 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
The sample at study endpoint will contain 50 children diagnosed with idiopathic autism and regression (AUT-R), 50 children diagnosed with idiopathic autism (and no history of regression; AUT-NR), 25 children with Rett's Disorder (RTT) and 50 typically developing children (TYP), matched on ethnicity, sex, chronological age and daycare enrollment. Matching for daycare setting (home versus setting with other children) will be attempted due to the potentially greater immunologic challenge experienced by children in daycare settings. The age range of all groups will be between 12 and 48 months at first visit (with the exception of the RTT group, which will include children up to age 6). We will over-recruit for children in the 12-36 month age range, in order to maximize participants of the age when regression associated with the autism diagnosis is most likely.
The Phenome Project Pilot will also enroll an additional 40 children with autism and 25 age-/sex-matched healthy controls, aged 2-6. In addition, as many as 25 children (ages 2 - 6 years) with developmental delays (without autism) will be recruited as contrast subjects.
Regression will be defined as:
Language loss: Loss of at least 3 spontaneously meaningful words (excluding mama or dada) used for at least a month, and lost for at least a month.
AND/OR
Nonverbal communication/social loss: Loss of more than one nonverbal communicative behavior (e.g. gestures, joint attention, eye contact, imagination, pretend play, sharing, showing, watching children, orienting to name, social smiling, social games, spontaneous imitation of actions, response to social overtures).
Autism groups (AUT-R & AUT-NR): Children with a diagnosis of autism or referral from professional with concerns of a diagnosis of autism will be evaluated with the ADI-R and ADOS. Those meeting research criteria for autism will be included.
Although there is overlap in the age period for regression specified in this protocol (regression between 15-30 months) and that described for childhood disintegrative disorder (CDD) (the DSM-IV criteria for CDD indicate apparently normal development for the first 2 years after birth), the criteria for CDD also indicate a diagnosis can only be made if symptoms are not better accounted for by another pervasive developmental disorder such as autism. Symptoms of CDD that separate it from autism include loss of acquired skills in areas such as motor skills and bowel or bladder control, while the focus of the current study is on regression in core symptoms of autism (i.e. socio-communicative skills). Thus, the current protocol will include children with regression over 2 who meet criteria for autism, but not those who only meet criteria for CDD.
Rett's Disorder group (RTT): Positive genetic screen for MeCP2 genetic mutation.
Typically Developing control group (TYP): No diagnosis of developmental delay and no first-degree relatives with history of developmental problems.
Developmental Delay group (DD): Developmental scores (Performance Quotient and Verbal Quotient) greater than 1.5 standard deviations below mean on Mullen Scales of Early Learning
EXCLUSION CRITERIA:
Contact: Patient Recruitment and Public Liaison Office | (800) 411-1222 | prpl@mail.cc.nih.gov |
Contact: TTY | 1-866-411-1010 |
United States, Maryland | |
National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
Bethesda, Maryland, United States, 20892 |
Study ID Numbers: | 060102, 06-M-0102 |
Study First Received: | March 1, 2006 |
Last Updated: | December 10, 2008 |
ClinicalTrials.gov Identifier: | NCT00298246 |
Health Authority: | United States: Federal Government |
Pervasive Developmental Disorder Early Development Longitudinal Etiology Characterization |
Pervasive Developmental Disorder PDD Autism Healthy Volunteer HV |
Child Development Disorders, Pervasive Developmental Disabilities Mental Disorders |
Autistic Disorder Mental Disorders Diagnosed in Childhood Healthy |